Health state utilities associated with adult attention-deficit/hyperactivity disorder
- PMID: 25114511
- PMCID: PMC4109631
- DOI: 10.2147/PPA.S62776
Health state utilities associated with adult attention-deficit/hyperactivity disorder
Abstract
Objectives: With growing awareness of the importance of adult attention-deficit/hyperactivity disorder (ADHD) treatment, cost-effectiveness analyses, including utilities, are needed to compare the value of treatment options. Although utilities have been reported for childhood ADHD, little is known about utilities representing adult ADHD. Therefore, the purpose of this study was to estimate utilities associated with adult ADHD.
Methods: Health-state descriptions of adult ADHD were drafted based on literature review, interviews with four clinicians, and clinical trial data. Health states were revised based on a pilot study with 26 participants. Final health states were rated in time trade-off interviews with general population respondents in London and Edinburgh, UK.
Results: A total of 158 participants completed interviews (mean age =47.0 years; 49.4% female; Edinburgh =80 participants). Mean (standard deviation [SD]) utilities were 0.82 (0.17), 0.68 (0.28), and 0.67 (0.28) for health states describing treatment responders (health state A), nonresponders (health state B), and untreated patients (health state C), respectively. Most participants rated health state A as preferable to B (n=92; 58.2%) and C (n=97; 61.4%). The majority rated B and C as equal (n=125; 79.1%). Paired Student's t-tests found that A had a significantly greater mean utility than B (t=10.0; P<0.0001) and C (t=10.2; P<0.0001).
Conclusion: The current study provides utilities that may be used in cost-utility models of treatment for adult ADHD. Results reflected clear differences between health states representing treatment responders and nonresponders/untreated patients. Current utilities were comparable to those previously reported for childhood ADHD.
Keywords: adult ADHD; time trade-off; utility.
Similar articles
-
Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations.Patient. 2011;4(4):247-57. doi: 10.2165/11592150-000000000-00000. Patient. 2011. PMID: 21995830
-
Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.Med Decis Making. 2005 Jan-Feb;25(1):56-70. doi: 10.1177/0272989X04273140. Med Decis Making. 2005. PMID: 15673582
-
Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.Qual Life Res. 2005 Apr;14(3):735-47. doi: 10.1007/pl00022070. Qual Life Res. 2005. PMID: 16022066
-
Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. NIH Consens Statement. 1998. PMID: 10868163 Review.
-
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD007813. doi: 10.1002/14651858.CD007813.pub3. Cochrane Database Syst Rev. 2018. PMID: 30091808 Free PMC article.
Cited by
-
A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK.Eur J Health Econ. 2018 Jan;19(1):21-35. doi: 10.1007/s10198-016-0864-4. Epub 2017 Jan 16. Eur J Health Econ. 2018. PMID: 28093662 Free PMC article.
-
Health-Related Quality of Life and Work Productivity of Adults With ADHD: A U.K. Web-Based Cross-Sectional Survey.J Atten Disord. 2018 Sep 14;23(13):1610-1623. doi: 10.1177/1087054718799367. Print 2019 Nov 1. J Atten Disord. 2018. PMID: 30215265 Free PMC article.
-
Valuing child and adolescent health: a qualitative study on different perspectives and priorities taken by the adult general public.Health Qual Life Outcomes. 2021 Sep 23;19(1):222. doi: 10.1186/s12955-021-01858-x. Health Qual Life Outcomes. 2021. PMID: 34556133 Free PMC article.
References
-
- Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36(2):167–179. - PubMed
-
- Faraone SV, Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord. 2005;9(2):384–391. - PubMed
-
- Mannuzza S, Klein RG, Moulton JL., 3rd Persistence of Attention- Deficit/Hyperactivity Disorder into adulthood: what have we learned from the prospective follow-up studies? J Atten Disord. 2003;7(2):93–100. - PubMed
-
- Brazier JR, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and Valuing Health benefits for Economic Evaluation. New York: Oxford University Press; 2007.
LinkOut - more resources
Full Text Sources
Other Literature Sources